Higher-riskArticle link

Focused Ultrasound for Alzheimer's Treatment: Opening the Blood-Brain Barrier for Drug Delivery

Focused ultrasound is an experimental technique that temporarily opens the blood-brain barrier, allowing Alzheimer's drugs to reach the brain more effectively. This approach is still in clinical trials and is not yet widely available. For caregivers, understanding how it works, what risks exist, and what costs may be involved can help you have informed conversations with your loved one's healthcare team. While it offers hope for improving drug delivery, it is not a cure and comes with important considerations.

Key points

  • Focused ultrasound temporarily opens the blood-brain barrier, allowing about 50% more Alzheimer's drug to reach the brain.
  • It is only available through clinical trials in the US; it is not FDA-approved for routine use.
  • Risks include mild headache, discomfort, and rare but serious side effects like seizure or brain swelling (ARIA).
  • Genetic testing for APOE4 is essential before considering this treatment due to increased risk of ARIA.
  • Costs are typically covered by the trial sponsor, but travel and time off may not be.
  • This is not a cure; it aims to slow progression by improving drug delivery to break up amyloid plaques.

What Is Focused Ultrasound and How Does It Help?

Focused ultrasound uses sound waves directed at a specific area of the brain to temporarily open the blood-brain barrier. The blood-brain barrier is a protective lining that normally keeps harmful substances out of the brain, but it also blocks many medications, including the newer anti-amyloid drugs like lecanemab and donanemab. By opening this barrier, focused ultrasound allows more of the drug to reach the brain tissue where it can work on breaking up amyloid plaques. In one clinical trial, researchers found that using focused ultrasound allowed about 50% more of the drug to enter the brain compared to standard intravenous infusion alone. This means that for people already receiving these infusions, the treatment could potentially be more effective at clearing the plaques that are a hallmark of Alzheimer's disease.

What Are the Risks and Side Effects?

Focused ultrasound is generally considered safe, but it does carry some risks. The most common side effects are mild and temporary, such as discomfort under the ultrasound transducer or a headache that lasts a few hours after treatment. More serious but rare risks include the possibility of seizure, which occurs in about 1 in 30,000 treatments. There is also a risk of small brain bleeds or swelling, particularly in people with certain genetic factors like the APOE4 gene. Because of this, doctors strongly recommend genetic testing before starting any treatment that involves opening the blood-brain barrier, as it affects the risk-benefit discussion. The procedure itself is non-invasive, meaning no incisions or needles are involved, but it does require multiple sessions over a prolonged period, often weekly for several months.

What Is the Cost and Availability?

Focused ultrasound for Alzheimer's is currently only available through clinical trials in the United States. It is not yet approved by the FDA for routine use, so it is not covered by Medicare or private insurance. The cost of participating in a trial is typically covered by the research sponsor, but travel and time off work may not be. If the treatment eventually becomes approved, the cost could be significant. For comparison, the newer anti-amyloid drugs alone can cost tens of thousands of dollars per year, and adding focused ultrasound would likely increase that. However, early studies suggest it could make the drugs more effective, potentially reducing the number of infusions needed or improving outcomes, which might offset some costs over time. Caregivers should discuss with the clinical trial coordinator what expenses might be involved and whether any financial assistance is available.

General caregiving information, not medical advice. Check medications and major care changes with your clinician.

Step-by-step

  1. Start by learning the basics: Focused ultrasound is not a treatment by itself but a way to deliver Alzheimer's drugs more effectively. Watch the 'Neurosurgeon Pioneers Alzheimer's, Addiction Treatments Using Ultrasound' video (link below) to see how the procedure works and hear from experts.

  2. Talk to your loved one's neurologist or memory clinic about whether focused ultrasound is an option. Because it is still experimental, you will need to find a clinical trial. The Alzheimer's Association TrialMatch tool (alz.org/trialmatch) can help you search for studies near you.

  3. If you find a trial, ask the study coordinator: 'What is the schedule of treatments? How many sessions are needed? What are the specific risks for someone with my loved one's health profile?' Write down the answers so you can compare options.

  4. Before enrolling, ensure your loved one has had genetic testing for the APOE4 gene. As Dr. Khushboo Verma explains in her video on the APOE gene, this information is crucial for understanding the risk of side effects like brain swelling or bleeding. Discuss the results with the trial doctor.

  5. Prepare for the logistics: Focused ultrasound treatments are usually done in a hospital or clinic with a special MRI-guided machine. Each session may take 1-2 hours, and your loved one will need to lie still. Ask if sedation is available if they have trouble staying calm.

  6. Keep a symptom diary during the trial. Note any headaches, confusion, or changes in behavior after each session. Report these to the trial team immediately. Mild headaches are common, but any new neurological symptoms should be evaluated.

  7. Understand that focused ultrasound does not stop Alzheimer's disease. As one caregiver described, 'Alzheimer's disease is still occurring in the brain... what it's doing is breaking up the plaque that is existing.' The goal is to slow progression, not reverse it. Set realistic expectations with your family.

  8. If the trial is not an option, ask your doctor about other ways to support drug delivery, such as ensuring your loved one takes their medications consistently and at the right time. There are no other approved methods to open the blood-brain barrier, so focused ultrasound is unique.

What not to do

  • Do not assume focused ultrasound is a cure. It is a delivery method, not a treatment itself. Expecting it to reverse Alzheimer's will lead to disappointment. Instead, focus on the potential to slow decline.

  • Do not skip genetic testing. The APOE4 gene significantly increases the risk of brain swelling (ARIA) with these treatments. Without testing, you cannot make an informed decision about risk.

  • Do not ignore mild side effects like headache. While common, they can be a sign of more serious issues. Always report them to the trial team, especially if they persist or worsen.

  • Do not pursue focused ultrasound outside of a clinical trial. There are no FDA-approved devices for this use in Alzheimer's, and unregulated providers may offer unsafe or ineffective treatments. Stick to registered trials listed on ClinicalTrials.gov.

  • Do not stop your loved one's current Alzheimer's medications without consulting their doctor. Focused ultrasound is typically added to existing treatments like donepezil or memantine, not a replacement.

  • Do not assume insurance will cover travel or lodging for a trial. Many trials do not reimburse these costs. Check with the study coordinator and explore local resources like the Alzheimer's Association for financial assistance.

Practical tools

  • Clinical Trial Search Checklist

    Use this checklist when looking for a focused ultrasound trial: (1) Confirm the trial is for early to moderate Alzheimer's (MMSE 10-26). (2) Ask if genetic testing is required and provided. (3) Get a written schedule of visits and procedures. (4) Ask about travel reimbursement. (5) Request a list of all possible side effects and their frequency. Keep this checklist in a notebook or on your phone.

  • Symptom Diary Template

    Create a simple diary with columns: Date, Time, Treatment Session Number, Symptoms (headache, dizziness, confusion, etc.), Severity (mild/moderate/severe), Duration, and Any Action Taken. Share this with the trial team at each visit. This helps them monitor for ARIA (brain swelling) early.

  • Questions to Ask the Trial Coordinator

    Print these questions: 'How many sessions will my loved one need?', 'What is the total time commitment per week?', 'What happens if they have a seizure?', 'Is there a 24-hour emergency number?', 'Can I stay in the room during treatment?', 'What are the costs I might have to pay out-of-pocket?' Having these written down ensures you don't forget.

  • Genetic Testing Discussion Guide

    Before APOE testing, discuss with the doctor: (1) How will the results affect treatment decisions? (2) Will the results be shared with insurance companies? (3) What support is available if the test shows increased risk? (4) How does the APOE4 gene affect the risk of brain swelling specifically? Write down the answers.

  • Video Resource: 'Neurosurgeon Pioneers Alzheimer's, Addiction Treatments Using Ultrasound'

    Watch this 60 Minutes segment to see the procedure in action and hear firsthand from the neurosurgeon who developed it. It provides a clear visual understanding of how ultrasound opens the blood-brain barrier. Use it to explain the treatment to other family members.

  • Support Group for Trial Participants

    Ask the trial coordinator if there is a support group for caregivers of participants. If not, consider joining an online group like the Alzheimer's Association ALZConnected, where you can connect with others going through similar experiences. Sharing tips and emotional support can be invaluable.

Discuss with your clinician

Ask your doctor: 'Is my loved one eligible for any focused ultrasound clinical trials? If not, why?'

Discuss: 'What is the risk of brain swelling or bleeding (ARIA) given my loved one's APOE status and overall health?'

Ask: 'How will we monitor for side effects during the trial? Will there be regular MRI scans?'

Discuss: 'If my loved one has a seizure during treatment, what is the emergency plan?'

Ask: 'Can my loved one continue their current Alzheimer's medications (like donepezil or memantine) during the trial?'

Discuss: 'What are the long-term effects of repeated blood-brain barrier opening? Is there any risk of infection or damage?'

Related guides

Sources